X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (220) 220
index medicus (198) 198
cardiac & cardiovascular systems (182) 182
male (161) 161
female (154) 154
middle aged (140) 140
aged (128) 128
treatment outcome (106) 106
percutaneous coronary intervention (99) 99
clopidogrel (91) 91
cardiovascular (67) 67
ticlopidine - analogs & derivatives (66) 66
abridged index medicus (59) 59
risk factors (55) 55
stents (54) 54
aspirin (53) 53
thrombosis (53) 53
heart attacks (52) 52
care and treatment (50) 50
myocardial infarction (47) 47
platelet aggregation inhibitors - therapeutic use (46) 46
time factors (46) 46
peripheral vascular disease (45) 45
follow-up studies (44) 44
platelet aggregation inhibitors - administration & dosage (44) 44
mortality (43) 43
adult (42) 42
cardiology (41) 41
hematology (41) 41
cardiac patients (40) 40
prospective studies (39) 39
acute coronary syndromes (38) 38
medical and health sciences (38) 38
medicin och hälsovetenskap (38) 38
cardiology and cardiovascular medicine (36) 36
clinical medicine (34) 34
antiplatelet therapy (33) 33
klinisk medicin (33) 33
therapy (33) 33
platelet reactivity (32) 32
angioplasty (31) 31
bleeding (31) 31
myocardial infarction - therapy (31) 31
ticlopidine - administration & dosage (31) 31
transluminal angioplasty (31) 31
coronary vessels (30) 30
drug therapy (30) 30
electrocardiography (30) 30
internal medicine (30) 30
cardiac and cardiovascular systems (29) 29
kardiologi (29) 29
angioplasty, balloon, coronary (28) 28
cardiovascular disease (28) 28
drug therapy, combination (28) 28
acute myocardial-infarction (27) 27
anticoagulants (27) 27
drug-eluting stents (27) 27
stent thrombosis (27) 27
aged, 80 and over (26) 26
hemorrhage - chemically induced (26) 26
metaanalysis (26) 26
myocardial-infarction (26) 26
risk (26) 26
stroke (26) 26
ticlopidine - therapeutic use (26) 26
percutaneous coronary intervention - adverse effects (25) 25
reperfusion (25) 25
implantation (24) 24
outcomes (24) 24
platelet function tests (24) 24
prognosis (24) 24
coronary artery disease (23) 23
heart attack (23) 23
intervention (23) 23
patients (23) 23
prasugrel (23) 23
predictive value of tests (23) 23
retrospective studies (23) 23
coronary angiography (22) 22
risk assessment (22) 22
stent (22) 22
atrial fibrillation (21) 21
coronary heart disease (21) 21
double-blind method (21) 21
dual antiplatelet therapy (21) 21
percutaneous coronary intervention - methods (21) 21
platelet aggregation inhibitors - adverse effects (21) 21
blood platelets (20) 20
studies (20) 20
task-force (20) 20
ticagrelor (20) 20
impact (19) 19
patient outcomes (19) 19
platelet aggregation - drug effects (19) 19
anticoagulants - administration & dosage (18) 18
clinical trials (18) 18
dose-response relationship, drug (18) 18
medical research (18) 18
analysis (17) 17
anticoagulants - therapeutic use (17) 17
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Thrombosis and Haemostasis, ISSN 0340-6245, 08/2016, Volume 116, Issue 2, pp. 369 - 378
SummaryPRIVATE-ATLANTIC (P2Y12 Receptor Inhibition with VASP Testing using Elisa kit during the ATLANTIC study) is a pre-specified substudy of the randomised,... 
STEMI | Morphine | Ticagrelor | Platelet reactivity | PCI
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2017, Volume 377, Issue 16, pp. 1513 - 1524
In this trial, dabigatran plus a P2Y 12 inhibitor was compared with warfarin plus a P2Y 12 inhibitor and aspirin after PCI in patients with atrial... 
MEDICINE, GENERAL & INTERNAL | PERCUTANEOUS CORONARY INTERVENTION | HEART-DISEASE | MYOCARDIAL-INFARCTION | ORAL ANTICOAGULATION | 2011 ACCF/AHA/SCAI GUIDELINE | AMERICAN-COLLEGE | ASSOCIATION TASK-FORCE | TRIPLE THERAPY | ANTIPLATELET THERAPY | CONSENSUS DOCUMENT | Dabigatran - adverse effects | Ticlopidine - therapeutic use | Humans | Middle Aged | Warfarin - adverse effects | Male | Risk | Dabigatran - therapeutic use | Incidence | Warfarin - therapeutic use | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Therapy, Combination - adverse effects | Adenosine - adverse effects | Adenosine - therapeutic use | Female | Aspirin - therapeutic use | Platelet Aggregation Inhibitors - therapeutic use | Ticagrelor | Purinergic P2Y Receptor Antagonists - therapeutic use | Hemorrhage - epidemiology | Atrial Fibrillation - drug therapy | Atrial Fibrillation - therapy | Anticoagulants - therapeutic use | Anticoagulants - adverse effects | Ticlopidine - analogs & derivatives | Adenosine - analogs & derivatives | Clopidogrel | Aged | Hemorrhage - chemically induced | Percutaneous Coronary Intervention | Warfarin | Atrial fibrillation | Dosage and administration | Research | Thromboembolism | Hemorrhage | Health aspects | Myocardial infarction | Cerebral infarction | Cardiac arrhythmia | Anticoagulants | Aspirin | Stroke | Embolisms | Preventive medicine | Thrombosis | Bleeding | Embolism | Fibrillation | Cardiology | Drug therapy | Drug dosages | Geriatrics | Kardiologi | Clinical Medicine | Cardiac and Cardiovascular Systems | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
Blood Coagulation & Fibrinolysis, ISSN 0957-5235, 09/2019, Volume 30, Issue 6, pp. 263 - 269
High on-treatment platelet reactivity (HPR) on P2Y12-inhibitors in patients treated with dual antiplatelet therapy is strongly associated with adverse... 
Journal Article
Revista Espanola de Cardiologia, ISSN 0300-8932, 06/2016, Volume 69, Issue 6, p. 608
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2013, Volume 369, Issue 23, pp. 2207 - 2217
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2013, Volume 62, Issue 24, pp. 2261 - 2273
Journal Article